Stryker Corporation Cash Flow Conversion Efficiency
Stryker Corporation cash flow conversion efficiency. Based on the latest financial reports, Stryker Corporation (SYK) has a cash flow conversion efficiency ratio of 0.053x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($1.26 Billion) by net assets ($23.99 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Stryker Corporation (1989–2025)
Cash flow conversion efficiency of Stryker Corporation from 1989 to 2025. This chart illustrates how Stryker Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SYK stock price and chart for real-time trading data and today's change.
Stryker Corporation Cash Flow Conversion Ratio Explained
Stryker Corporation cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Stryker Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Stryker Corporation ranked by their cash flow conversion efficiency. Also see Stryker Corporation market capitalisation for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Bank of Montreal
TO:BMO
|
-0.016x |
|
SIEMENS ENERGY AG ADR/1
F:ENR0
|
0.272x |
|
BP p.l.c
MX:BPN
|
0.142x |
|
SCHNEIDER ELECTR.ADR/1/5
F:SNDB
|
N/A |
|
Siemens Energy AG
F:ENR
|
0.272x |
|
Progressive Corp
NYSE:PGR
|
0.105x |
|
Lowe's Companies Inc
NYSE:LOW
|
-0.361x |
|
Prologis Inc
NYSE:PLD
|
0.023x |
Annual Cash Flow Conversion Efficiency for Stryker Corporation (1989–2025)
The table below shows the annual cash flow conversion efficiency of Stryker Corporation from 1989 to 2025. Review Stryker Corporation free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $22.42 Billion | $5.04 Billion | 0.225x | +9.43% |
| 2024-12-31 | $20.63 Billion | $4.24 Billion | 0.206x | +3.00% |
| 2023-12-31 | $18.59 Billion | $3.71 Billion | 0.200x | +26.39% |
| 2022-12-31 | $16.62 Billion | $2.62 Billion | 0.158x | -28.00% |
| 2021-12-31 | $14.88 Billion | $3.26 Billion | 0.219x | -12.43% |
| 2020-12-31 | $13.08 Billion | $3.28 Billion | 0.250x | +46.40% |
| 2019-12-31 | $12.81 Billion | $2.19 Billion | 0.171x | -23.11% |
| 2018-12-31 | $11.73 Billion | $2.61 Billion | 0.223x | +42.64% |
| 2017-12-31 | $9.99 Billion | $1.56 Billion | 0.156x | -22.21% |
| 2016-12-31 | $9.55 Billion | $1.92 Billion | 0.201x | +89.84% |
| 2015-12-31 | $8.51 Billion | $899.00 Million | 0.106x | -49.05% |
| 2014-12-31 | $8.60 Billion | $1.78 Billion | 0.207x | -0.56% |
| 2013-12-31 | $9.05 Billion | $1.89 Billion | 0.208x | +8.16% |
| 2012-12-31 | $8.60 Billion | $1.66 Billion | 0.193x | +3.27% |
| 2011-12-31 | $7.68 Billion | $1.43 Billion | 0.187x | -13.47% |
| 2010-12-31 | $7.17 Billion | $1.55 Billion | 0.216x | -2.61% |
| 2009-12-31 | $6.60 Billion | $1.46 Billion | 0.221x | +1.84% |
| 2008-12-31 | $5.41 Billion | $1.18 Billion | 0.217x | +13.76% |
| 2007-12-31 | $5.38 Billion | $1.03 Billion | 0.191x | -7.61% |
| 2006-12-31 | $4.19 Billion | $867.30 Million | 0.207x | -22.10% |
| 2005-12-31 | $3.25 Billion | $863.80 Million | 0.266x | +24.94% |
| 2004-12-31 | $2.79 Billion | $593.30 Million | 0.213x | -29.36% |
| 2003-12-31 | $2.15 Billion | $648.50 Million | 0.301x | -10.52% |
| 2002-12-31 | $1.50 Billion | $503.90 Million | 0.336x | -24.14% |
| 2001-12-31 | $1.06 Billion | $468.30 Million | 0.443x | +14.24% |
| 2000-12-31 | $854.90 Million | $331.80 Million | 0.388x | -8.23% |
| 1999-12-31 | $671.50 Million | $284.00 Million | 0.423x | +83.08% |
| 1998-12-31 | $668.80 Million | $154.50 Million | 0.231x | +63.01% |
| 1997-12-31 | $648.50 Million | $91.90 Million | 0.142x | -57.25% |
| 1996-12-31 | $616.30 Million | $204.30 Million | 0.331x | +66.28% |
| 1995-12-31 | $559.30 Million | $111.50 Million | 0.199x | -6.48% |
| 1994-12-31 | $458.30 Million | $97.70 Million | 0.213x | -28.59% |
| 1993-12-31 | $288.40 Million | $86.10 Million | 0.299x | +36.79% |
| 1992-12-31 | $232.30 Million | $50.70 Million | 0.218x | +4.42% |
| 1991-12-31 | $179.90 Million | $37.60 Million | 0.209x | -36.00% |
| 1990-12-31 | $147.90 Million | $48.30 Million | 0.327x | +70.12% |
| 1989-12-31 | $112.00 Million | $21.50 Million | 0.192x | -- |
About Stryker Corporation
Stryker Corporation operates as a medical technology company in the United States and internationally. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, patient and caregiver safety technologies, navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment … Read more